Member Info for Jace86

Do the numbers. How many people would be eligible for screening in China. Say we grab ten percent of them? £10 per go for our royalty.

Then America. How many again eligible. Say £30 per go for royalty.

Then Europe, then UK... and so on.

Then other cancer types...

When we are looking at our potential max shares in issue and comparing this to an offer price you need to be talking multiple quids.

40p is still a pittance for this.

LowiePete - there may not be news from China for a while yet.

As for being ripped off? Think of who we are dealing with. Bosch and Sinopharm.

Our kit is patented.

If anyone bought in purely for CDT, you're doing it wrong.

Close your accounts.

Price gone bananas.

I wouldn't think that long either. Trials against already known results would be just a few hours.

Putting together instructions etc for the medical device into a leaflet would be more important.

How long then for a marker? Trial design already underway. So I can't envisage this being far off.

Yeah too cheap £1 per share...

If people run the numbers and should production and demand be there only after regular arrangements are set up and running should there be any consideration. We'd be past quids then.

Anyway, we are too soon. Trials etc first.

Great finish.

And no, don't think of selling even at 30p 😉

£1 is too low imo... The company I suspect will be worth many billions.

Far too much energy being spent on this option.

Focus on our test. Our stake in AZD1656 was only ever going to be up to £5m depending on what came of it.

Now compare that to hundreds of millions of people who could be tested for lung cancer and what that equates to in terms of royalties.

Mole hill Vs mountains.

Even 40p is an undersell.

Remember, China royalty is 10% and USA 15%.

Tens of millions of potential screening targets in each country.

A challenge would be to ensure production could meet demand.

Very. I still don't believe people understand the potential here.

Add in the million dump earlier too...

Hopefully gone.

A lot more should the trial produce a strong result and an established market form.

Follow directors talk and stock box on twitter. We pop up on there every now and again.

Given some of the trading I see in this share, I'm of the opinion that people genuinely have no clue what they are buying most of the time...

How are they not bankrupt?

Lol £25m...

How many in America alone might be eligible for screening?

How much might the test sell for? Say 250... Royalty is 15% on US.

Take a million screens per year out of the tens viable. What's your revs?

Crude I know...

But simple numbers to help people start to think of what the value should be...

That's just the US. Now apply the same mindset to China, rest of Asia, Europe, UK and even if we go there, South America and the rest of North America and central.

As oapk20 has said, this is not something that goes away like the propaganda did for a virus... This is something that will likely never go away.

"Success" - oh no, run a mile lol...

We have the merger vote coming tomorrow. That should put raise concerns at ease. There is also a 500k convertible loan if we really need it.

It would have been nice early on to name drop them. First we've heard of this collaboration.